Â鶹AV

This program has been postponed. 2025 dates TBD.

Back to the Continuing Education Home page

This program has been postponed. 2025 dates TBD.

Delivery: Hybrid (both in-person and live remote learning)

1. Friday, Oct. 25, 2024 - Online via Zoom from 1  - 3 p.m.
2. Friday, Nov. 8, 2024 - In-Person from 9:30 a.m. - 3:00 p.m. (1/2 hr. lunch break - lunch will be provided)
3. Friday, Nov. 15, 2024 - Online via Zoom from 1  - 3 p.m.

This three-part continuing education series provides a foundational understanding of the research, clinical practice, and policy landscape of psychedelic-assisted psychotherapy. Through live and remote learning sessions, trainees will gain an introduction to the efficacy, research base, and therapeutic approach of these therapies, as well as an overview of the policy landscape and how this growing movement impacts the field of social work. Through a 5-hour, in-person session, trainees will gain an overview of the specific therapeutic skills most often employed in psychedelic therapy facilitation and learn how these skills fit into existing frameworks for clinical practice. This session will feature a particular focus on applying the skills of psychedelic facilitation through role-play exercises and a case study of a client receiving ketamine-assisted psychotherapy—the only psychedelic therapy legally accessible in Pennsylvania outside of a clinical trial context. Throughout this course, issues of diversity, inclusion, equitable access, and indigenous reciprocity are addressed as they relate to the research and practice of psychedelic medicine.

Learning Objectives

Participants of this program will learn:(1) How ketamine, MDMA, and psilocybin are being studied and used clinically alongside psychotherapy in the U.S.; (2) Specific skills core to psychedelic facilitation, as well as a framework for understanding how psychedelic facilitation fits into more traditional psychotherapeutic techniques. (3) How social workers can work legally with these medicines and the role that social workers can play—both clinically and in advocacy and organizational leadership—in shaping the psychedelic renaissance.

This series is appropriate for all levels of clinical practitioners.

Instructor

Courtney Hutchison, LSW, MSS, MPH is a licensed social worker, psychotherapist, and psychedelic facilitator practicing in Philadelphia, PA. She specializes in the treatment and research of trauma-related disorders and relationship violence, with a special focus on the intersections of these concerns with psychedelic psychotherapy. Since 2020, she has worked at SoundMind Institute, a West Philadelphia clinic and training program focusing on bringing equity to the psychedelic ecosystem, where she provides ketamine-assisted psychotherapy, co-leads trainings in psychedelic facilitation, and manages operations for one of the longest-running psychedelic facilitator training programs in the nation. She holds a master’s degree in social service from Bryn Mawr Â鶹AV School of Social Work and Social Research, a master’s degree in public health from UC Berkeley, a bachelor’s degree in international relations from Brown University. She is in her final year of doctoral work at Rutgers School of Social Work. Earlier in her career, Courtney was a medical journalist and racial equity policy advocate, and a deep appreciation of the systemic forces that shape opportunities for health continue to drive her clinical and research endeavors today.

Cost | CEUs

Program Cost: $265 for the series (Partial registration is not available for this program.)

Discount Rate: Not available for this program.

CEUs: 9

Register Here